{
    "nctId": "NCT00213980",
    "briefTitle": "Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer",
    "officialTitle": "Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 68,
    "primaryOutcomeMeasure": "Change in Bone Mineral Density (BMD) From Baseline to 1 Year",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women, Stage III or axillary node positive\n* Currently disease free of breast cancer and other invasive malignancies at the time of registration\n* No concurrent use of bisphosphonates\n\nExclusion Criteria:\n\n* Metastatic disease",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}